News

AddToAny

Google+ Facebook Twitter Twitter

"Sepsis causes one in five deaths"

Twice as many people as previously believed are dying of sepsis worldwide, according to a new analysis.

Among them are a disproportionately high number of children who are from poor areas.

Led by researchers at the medical schools of the University of Pittsburgh and the University of Washington, the study revealed 48.9 million global cases of sepsis in 2017 and 11 million deaths, representing one in five deaths worldwide.

The majority of sepsis – 85% – occurred in countries with low- or middle-sociodemographic status.

The highest burdens were found in sub-Saharan Africa; the South Pacific islands; and South, East, and Southeast Asia.

Sepsis incidence was higher among females than males and peaked in early childhood, with more than 40% of cases in children under five.

Dr Mohsen Naghavi, senior study author, said: “We are alarmed to find sepsis deaths are much higher than previously estimated, especially as the condition is both preventable and treatable.

“We need renewed focus on sepsis prevention among newborns and antimicrobial resistance – an important driver of the condition.”

For their analysis, Naghavi and colleagues leveraged the Global Burden of Disease study, a comprehensive epidemiological analysis, which reports on 282 primary causes of death, not including sepsis, which is considered an intermediate cause of death. A primary cause of death is the underlying condition (such as cancer), which leads to the intermediate cause (sepsis) that ultimately results in death.

Previous estimates were limited because they relied upon hospital databases from a select group of middle- and high-income countries.  

The new findings are unprecedented as they represent mortality both in and out of the hospital.  

bit.ly/2TI8yiK

Image credit | iStock

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top